134 related articles for article (PubMed ID: 38802132)
1. Intraoral hemorrhagic bullae as the first sign of immunoglobulin light chain amyloidosis.
Dominguez-Lopez RM; Naharro-Rodriguez J
CMAJ; 2024 May; 196(20):E705. PubMed ID: 38802132
[No Abstract] [Full Text] [Related]
2. Mucocutaneous Xanthodermatosis as Initial Presentation of Immunoglobulin Light Chain Amyloidosis.
da Fonseca AM; Furlan BB; Irffi GP; de Oliveira GB; Souza EG; Rezende SM
Am J Med; 2022 Jun; 135(6):724-727. PubMed ID: 35081385
[No Abstract] [Full Text] [Related]
3. Bilateral carpal tunnel syndrome preceding haemorrhagic bullae in an older adult.
Tippayawat T; Chularojanamontri L; Ongsri P; Eimpunth S; Bunyaratavej S
Clin Exp Dermatol; 2022 Feb; 47(2):484-487. PubMed ID: 34854106
[No Abstract] [Full Text] [Related]
4. [Anesthesia for a man with bullous amyloidosis as the first sign of advanced primary amyloidosis].
Robles M; Rodríguez E; Rojas MA; Sarmiento MA
Rev Esp Anestesiol Reanim; 2010 Dec; 57(10):671-2. PubMed ID: 22283021
[No Abstract] [Full Text] [Related]
5. Recurrent hemorrhagic bullae of oral cavity and cranial nerve palsy: two rare manifestations at the onset of light chain (AL) amyloidosis in the same patient.
Jeannin G; Econimo L; Morassi L; Faggiano P; Nardi M; Gregorini G
Amyloid; 2011 Jun; 18 Suppl 1():119-20. PubMed ID: 21838456
[No Abstract] [Full Text] [Related]
6. A Case of Disseminated Systemic Light-Chain Amyloidosis with Coagulopathy.
Murphy P
Am J Med; 2023 Mar; 136(3):e51. PubMed ID: 36796957
[No Abstract] [Full Text] [Related]
7. Systemic Light Chain Amyloidosis.
Sanchorawala V
N Engl J Med; 2024 Jun; 390(24):2295-2307. PubMed ID: 38924733
[No Abstract] [Full Text] [Related]
8. Systemic amyloidosis presented with leonine facies.
Liu JW; Tan Y; Chen T; Qian YT; Ma DL
QJM; 2024 Apr; 117(4):287-288. PubMed ID: 38060280
[No Abstract] [Full Text] [Related]
9. Perioral skin thickening revealing AL amyloidosis.
Billard K; Arnulf B; Kottler D; Mirouse A; Harel S; Royer B; Bagot M; Jachiet M; Bouaziz JD; Mahévas T;
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e703-e705. PubMed ID: 35445455
[No Abstract] [Full Text] [Related]
10. Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.
Guo YM; Takahashi N; Miyabe K; Yoshida M; Abe F; Yamashita T; Nara M; Yoshioka T; Ohashi K; Goto A; Takahashi N
Intern Med; 2019 Oct; 58(20):3039-3043. PubMed ID: 31243220
[TBL] [Abstract][Full Text] [Related]
11. Oral purpura as the first manifestation of primary systemic amyloidosis.
McCormick RS; Sloan P; Farr D; Carrozzo M
Br J Oral Maxillofac Surg; 2016 Jul; 54(6):697-9. PubMed ID: 26708800
[TBL] [Abstract][Full Text] [Related]
12. Reversing the poor prognosis of primary amyloid light‑chain amyloidosis with cardiac involvement.
Jurczyszyn A; Rajtar-Salwa R; Sorysz D; Zawiślak B; Suska A; Szostek M
Pol Arch Intern Med; 2022 Apr; 132(4):. PubMed ID: 35076194
[No Abstract] [Full Text] [Related]
13. Pinch Purpura: A Cutaneous Manifestation of Systemic Amyloidosis.
Agarwal A; Chang DS; Selim MA; Penrose CT; Chudgar SM; Cardones AR
Am J Med; 2015 Sep; 128(9):e3-4. PubMed ID: 25910788
[No Abstract] [Full Text] [Related]
14. Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.
Draghici M; Jercan A; Badelita SN; Irimia RM; Bastian AE; Dobrea C; Popescu M; Coriu D
Medicine (Baltimore); 2021 Dec; 100(51):e28267. PubMed ID: 34941106
[TBL] [Abstract][Full Text] [Related]
15. [Bullosa haemorrhagica oralis. A review of the literature and case report].
von Arx T
Schweiz Monatsschr Zahnmed; 1998; 108(10):989-96. PubMed ID: 9819963
[No Abstract] [Full Text] [Related]
16. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA
Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413
[TBL] [Abstract][Full Text] [Related]
17. Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis.
Ravichandran S; Law S; Mahmood S; Wisniowski B; Foard D; Fontana M; Martinez-Naharro A; Whelan C; Gillmore JD; Lachmann HJ; Hawkins PN; Wechalekar AD
Leukemia; 2022 Apr; 36(4):1180-1184. PubMed ID: 34987193
[No Abstract] [Full Text] [Related]
18. Trends and causes of hospitalizations in patients with amyloidosis.
Patil N; Arora S; Qamar A; Strassle PD; Alexander KM; Fatima A; Maurer MS; Grodin JL; Pandey A
Amyloid; 2019 Sep; 26(3):177-178. PubMed ID: 31172802
[No Abstract] [Full Text] [Related]
19. Long standing polyneuropathy as a form of presentation of primary systemic amyloidosis.
Jiménez Caballero PE
Neurologia; 2012 Sep; 27(7):447-8. PubMed ID: 22217524
[No Abstract] [Full Text] [Related]
20. Systemic amyloidosis in a patient presenting with myopathy, peripheral oedema and proteinuria.
Bywater L; Gist AC; Muthalaly RG; Loh J; Simpson I; White AJ; Lim AK
Med J Aust; 2022 Sep; 217(5):232-234. PubMed ID: 35924379
[No Abstract] [Full Text] [Related]
[Next] [New Search]
